vTv Therapeutics Inc.
NASDAQ:VTVTBiotechnology
Healthcare
$16.36 +1.47%
+$0.50 today
- Market cap
- $64.69M
- Beta
- 0.27
- P/E (TTM)
- 128.7
- EPS (TTM)
- $0.27
52W Low $14.00High $44.00
Volume 0.02M
Average 0.05M
Balance Sheet
Inspect the capital base behind the business.
Assets
$89.90M
FY 2025 · Annual
+134.9% YoYLiabilities
$25.46M
FY 2025 · Annual
+6.2% YoYEquity
$64.44M
FY 2025 · Annual
+350.6% YoYBalance Sheet
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 13.42M | 12.13M | 9.45M | 36.75M | 88.93M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 57K | 12.42M | 102K | 62K | 0 |
| Inventory | 100K | 0 | 0 | 0 | 0 |
| Other Current Assets | 35K | 15K | 65K | 113K | 218K |
| Total Current Assets | 15.62M | 27.09M | 10.66M | 38.11M | 89.89M |
| Property, Plant & Equipment (Net) | 680K | 556K | 361K | 153K | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 9.17M | 5.59M | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 0 | 0 | 0 | 6K |
| Total Non-current Assets | 9.85M | 6.14M | 361K | 153K | 6K |
| Total Assets | 25.47M | 33.24M | 11.02M | 38.27M | 89.9M |
| Account Payables | 1.88M | 2.46M | 4.08M | 939K | 1.13M |
| Short-term Debt | 256K | 224K | 191K | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 35K | 17K | 17K | 0 | 0 |
| Other Current Liabilities | 3.2M | 788K | 4.7M | 1.51M | 2.17M |
| Total Current Liabilities | 8.5M | 7.71M | 10.62M | 5.2M | 6.64M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 18.67M | 18.67M | 18.67M | 18.67M |
| Other Non-current Liabilities | 1.26M | 684K | 110K | 100K | 152K |
| Total Non-current Liabilities | 1.75M | 19.69M | 18.95M | 18.77M | 18.82M |
| Total Liabilities | 10.25M | 27.4M | 29.57M | 23.97M | 25.46M |
| Common Stock | 901K | 27K | 27K | 32K | 39K |
| Retained Earnings | (248.83M) | (265.52M) | (281.04M) | (299.72M) | (326.69M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 24.96M | 16.58M | 6.13M | 2.1M | 0 |
| Total Equity | 15.22M | 5.84M | (18.55M) | 14.3M | 64.44M |
| Total Debt | 932K | 716K | 529K | 169K | 0 |
| Net Debt | (12.48M) | (11.41M) | (8.92M) | (36.58M) | (88.93M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $98.1M |
| Other Current | $722.0K |
| Total Current Assets | $98.8M |
| Other Non-current | $5.0K |
| Total Non-current Assets | $5.0K |
| Total Assets | $98.8M |
Analysis
Selected assets total $98.8M for Latest. The largest visible component is Cash & Equivalents at $98.1M, about 99.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| SC 13G/A | SC 13G/A filing | Oct 8, 2026 | |
| 8-K | Current report | Oct 6, 2026 | |
| 10-Q | Quarterly report | Aug 6, 2026 |
How much cash does VTVT have?
vTv Therapeutics Inc. (VTVT) reported $88.93M in cash and equivalents in fiscal 2025.
How much debt does VTVT carry?
vTv Therapeutics Inc. (VTVT) reported $0.00 of total debt, with net debt of -$88.93M.
Continue the stock analysis
Jump to another research area for this company.